The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Britannia Life Sciences Inc. (BLAB:CA) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Britannia Life Sciences Inc. stock forecast from 0 analysts, the average analyst target price for Britannia Life Sciences Inc. is not available over the next 12 months. Britannia Life Sciences Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Britannia Life Sciences Inc. is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Britannia Life Sciences Inc.’s stock price was CAD 0.05. Britannia Life Sciences Inc.’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -28.57% over the last year.
No recent analyst target price found for Britannia Life Sciences Inc.
No recent average analyst rating found for Britannia Life Sciences Inc.
Company Overview Britannia Life Sciences Inc.
Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services primarily to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is headquartered in Toronto, Canada. Address: 120 Adelaide Street West, Toronto, ON, Canada, M5H 1T1 Read Less
Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services primarily to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is headquartered in Toronto, Canada. Address:...Read More
N/A
N/A
0
N/A
CAD
Canada
Adjusted Closing Price for Britannia Life Sciences Inc. (BLAB:CA)
Loading...
Unadjusted Closing Price for Britannia Life Sciences Inc. (BLAB:CA)
Loading...
Share Trading Volume for Britannia Life Sciences Inc. Shares
Loading...
Compare Performance of Britannia Life Sciences Inc. Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for BLAB:CA
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Britannia Life Sciences Inc. (Sector: Biotechnology )
Frequently Asked Questions About Britannia Life Sciences Inc. (BLAB:CA) Stock
Stock Target Advisor's fundamental analysis for Britannia Life Sciences Inc.'s stock is Neutral.
Unfortunately we do not have enough data on BLAB:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BLAB:CA's stock to indicate what its average analyst target is.
BLAB:CA stock's Price/Earning ratio is 5.00.
Our analysis grades BLAB:CA stock's Price / Earning ratio at F. This means that BLAB:CA stock's Price/Earning ratio is above 75% of the stocks in the Biotechnology sector in the CNSX exchange.
Based on this BLAB:CA may be a overvalued for its sector.
The last closing price of BLAB:CA's stock was CAD 0.05.
The most recent market capitalization for BLAB:CA is CAD 8.11M.
Unfortunately we do not have enough analyst data on BLAB:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Britannia Life Sciences Inc.'s stock.
As per our most recent records Britannia Life Sciences Inc. has 0 Employees.
Sorry we do not have any infomation available on Britannia Life Sciences Inc.'s address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Britannia Life Sciences Inc. (BLAB:CA) Stock
Stock Target Advisor's fundamental analysis for Britannia Life Sciences Inc.'s stock is Neutral.
Unfortunately we do not have enough data on BLAB:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BLAB:CA's stock to indicate what its average analyst target is.
BLAB:CA stock's Price/Earning ratio is 5.00.
Our analysis grades BLAB:CA stock's Price / Earning ratio at F. This means that BLAB:CA stock's Price/Earning ratio is above 75% of the stocks in the Biotechnology sector in the CNSX exchange.
Based on this BLAB:CA may be a overvalued for its sector.
The last closing price of BLAB:CA's stock was CAD 0.05.
The most recent market capitalization for BLAB:CA is CAD 8.11M.
Unfortunately we do not have enough analyst data on BLAB:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Britannia Life Sciences Inc.'s stock.
As per our most recent records Britannia Life Sciences Inc. has 0 Employees.
Sorry we do not have any infomation available on Britannia Life Sciences Inc.'s address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BLAB:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
